Chris Van Vliet

BAP1 Loss by Immunohistochemistry Predicts Improved Survival to First-Line Platinum and Pemetrexed Chemotherapy for Patients With Pleural Mesothelioma: A Validation Study

Amber Louw, Vasiliki Panou, Weronika Maria Szejniuk et al. · Journal of Thoracic Oncology · 2022 · 62 citations · Full text

Medicine, Oncology, Pathology +17

COO and MYC/BCL2 status do not predict outcome among patients with stage I/II DLBCL: a retrospective multicenter study

Allison Barraclough, Musa Alzahrani, Marianne Schmidt Ettrup et al. · Blood Advances · 2019 · 52 citations · Full text

Medicine, Hematology, Oncology +17

Case report: NTRK1-rearranged cervical sarcoma with fibrosarcoma like morphology presenting in a 13-year-old managed with a neo-adjuvant TRK-inhibitor and surgical excision

Elizabeth A Goulding, Philip Morreau, M. De Silva et al. · Gynecologic Oncology Reports · 2021 · 28 citations · Full text

Medicine, Oncology, Surgery +13

Equivocal <i><scp>ALK</scp></i> fluorescence <i>in‐situ</i> hybridization (<scp>FISH</scp>) cases may benefit from ancillary <i><scp>ALK</scp></i><scp>FISH</scp> probe testing

Christina Selinger, Wendy A. Cooper, Trina Lum et al. · Histopathology · 2015 · 16 citations

Medicine, Molecular Genetics, Oncology +15

Mitotically Active Nevus and Nevoid Melanoma: A Clinicopathological and Molecular Study

Nima Mesbah Ardakani, Shalinder Singh, Carla Thomas et al. · American Journal of Dermatopathology · 2020 · 16 citations

Medicine, Dermatology, Pathology +17